Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2021-07-09 00:00:00 ET · period of report 2021-07-07 · accession 0001395064-21-000153 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-09 | 2021-07-07 | PHAT | TAKEDA PHARMACEUTICAL CO LTD | 10% | S - Sale | $35.05 | -2,609 | 871.3K | -0.3% | -$91.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-07 | S | D | 2,609 | $35.05 | 871,305 | D | — | — | (F2) Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.26. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer. |